ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Dexmedetomidine attenuates hypoxia/reoxygenation-induced cardiomyocyte injury in association with ADRA2A/ADRA2B and Notch1/Hes1 modulation.
Dinghao Xue et al.PubMed ↗Publisher ↗
No numbers read from the abstract.